Predictive Oncology Inc (NASDAQ: POAI) stock rallied 22.68% during the premarket session despite not making any substantial moves today.
The lack of news drivers behind today’s rally point to a push by retail investors to accumulate the precision medicine company’s shares, in what could turn into a short squeeze if the rally continues.
Meanwhile, the last important announcement from Predictive Oncology was the release of its Q2 earnings results on August 12, 2021.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
The firm generated $350,200 in revenues during the three months, representing a 92% improvement to the figures reported a year earlier.
At the time, the firm noted that its subsidiary TumorGenesis had partnered with Swedish firm Cellevate AB to create cutting-edge tools for use by researchers in developing treatments for challenging diseases.
Predictive Oncology’s subsidiaries TumorGenesis and Soluble Biotech were constructing GMP facilities to help expand its services and meet its clients growing needs.
The firm had a cash balance of $44.9 million at the end of Q2 from various fundraising activities, including issuing new shares.
With the above fundamentals coupled with the company’s excellent financial condition, we could say that the firm’s prospects looked quite promising, yet its share price has been trading sideways since then.
While fundamental drivers did not drive today’s rally, many hope to get a multi-day rally, but only time will tell. Meanwhile, I will be watching how the stock trades at the open.
*This is not investment advice.
Predictive Oncology stock price.
Predictive Oncology stock rose 22.68% premarket to trade at $1.20, increasing from Tuesday’s closing price of $0.97.
